Massey, Suena H.
Schuette, Stephanie A.
Pournajafi-Nazarloo, Hossein
Wisner, Katherine L.
Carter, C. Sue
Funding for this research was provided by:
National Institute on Drug Abuse (K23DA037913)
Northwestern Memorial Foundation (9/12/13 agreement date)
Article History
Received: 18 November 2015
Accepted: 29 February 2016
First Online: 8 March 2016
Compliance with ethical standards
: All procedures were approved by the Institutional Review Board of Northwestern University prior to conduct and were performed in accordance with the ethical standards as laid down in the 1964 Declaration of Helsinki and its later amendments.
: This work was funded by the Evergreen Invitational Women’s Health Grant from the Northwestern Memorial Foundation to Dr. Massey (9/12/13 agreement date), and grant K23 DA037913 from the National Institute on Drug Abuse (NIDA) to Dr. Massey. The Evergreen Invitational, Northwestern Memorial Foundation, and NIDA had no role in the study design, collection, analysis or interpretation of data, writing the manuscript, or the decision to submit the paper for publication.
: The Department of Psychiatry at Northwestern University received contractual fees for Dr. Wisner’s consultation to Quinn Emanuel Urquhart & Sullivan, LLP (New York City), who represents Pfizer Pharmaceutical Company.